Ailux is an emerging, AI-native, next-generation global biopharma designed to systematically bring transformative medicines to patients. By integrating proprietary computational models with state-of-the-art wet lab capabilities, we aim to tackle previously undruggable targets and design molecules with novel therapeutic profiles.